UPDATE: Xenon Genetics Raises Additional $2.6M in Second Round Financing | GenomeWeb

This article has been updated from a previous version .

NEW YORK, May 4 - Canadian population genetics company Xenon Genetics completed its second round of financing, worth $2.6 million, adding to $45 million raised in early April, the company said Friday. 

The additional financing "is going to allow us to continue to expand more quickly," said company spokeswoman Ann David. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genetic link between birth weight and adult-onset diseases, and more.

Even with all the current enthusiasm for gene therapies, Tech Review cautions that they are mostly in the early stages of development.

DNA phenotyping puts a potential face to a suspect in a nearly 25-year-old murder, the AP reports.

Researchers discuss the need for antibody standards at a meeting, NPR reports.